Seeking Alpha

Alexion Pharmaceuticals (ALXN -1.2%) says its Board of Directors has authorized a $400M stock...

Alexion Pharmaceuticals (ALXN -1.2%) says its Board of Directors has authorized a $400M stock buyback. The Board's authorization is open-ended and doesn't establish a timeframe for the purchases, and the company expects to fund all repurchases from cash on hand and future cash flows from operations.
Comments (1)
  • ThLizrd
    , contributor
    Comment (1) | Send Message
     
    "Net present value of expected future cash flows" on SALE now at Alexion! ---thlizrd
    9 Nov 2012, 06:05 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|